Cargando…

Cost-Utility Analysis of Universal Maternal Pertussis Immunisation in Thailand: A Comparison of Two Model Structures

OBJECTIVES: This study aimed to assess the cost-effectiveness of introducing universal maternal pertussis immunisation under the national vaccine programme in Thailand. METHODS: We conducted a cost-utility analysis from a societal perspective to compare maternal vaccination with (1) TdaP vaccine, (2...

Descripción completa

Detalles Bibliográficos
Autores principales:	Botwright, Siobhan, Win, Ei Mon, Kapol, Nattiya, Benjawan, Sirikanlaya, Teerawattananon, Yot
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2022
Materias:	Original Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9644008/ https://www.ncbi.nlm.nih.gov/pubmed/36348154 http://dx.doi.org/10.1007/s40273-022-01207-w

Ejemplares similares

Economic evaluation of pegylated interferon plus ribavirin for treatment of chronic hepatitis C in Thailand: genotype 1 and 6
por: Kapol, Nattiya, et al.
Publicado: (2016)

Planning for future COVID-19 vaccine procurement
por: Teerawattananon, Yot, et al.
Publicado: (2022)

Cost-utility analysis of the screening program for early oral cancer detection in Thailand
por: Kumdee, Chutima, et al.
Publicado: (2018)

Comparing 3 Approaches for Making Vaccine Adoption Decisions in Thailand
por: Rattanavipapong, Waranya, et al.
Publicado: (2020)

Lessons drawn from research utilization in the maternal iodine supplementation policy development in Thailand
por: Tonmukayakul, Utsana, et al.
Publicado: (2012)

Reviewing the evidence on effectiveness and cost-effectiveness of HIV prevention strategies in Thailand
por: Pattanaphesaj, Juntana, et al.
Publicado: (2010)

Maternal pertussis immunisation: clinical gains and epidemiological legacy
por: Bento, Ana I, et al.
Publicado: (2017)

Cost-utility analysis of adjuvant imatinib treatment in patients with high risk of recurrence after gastrointestinal stromal tumour (GIST) resection in Thailand
por: Bussabawalai, Thanaporn, et al.
Publicado: (2019)

A cost-utility analysis of drug treatments in patients with HBeAg-positive chronic hepatitis B in Thailand
por: Tantai, Narisa, et al.
Publicado: (2014)

A cost-utility and budget impact analysis of allogeneic hematopoietic stem cell transplantation for severe thalassemic patients in Thailand
por: Leelahavarong, Pattara, et al.
Publicado: (2010)

Using an experiment among clinical experts to determine the cost and clinical impact of rapid whole exome sequencing in acute pediatric settings
por: Kapol, Nattiya, et al.
Publicado: (2023)

The economic costs of alcohol consumption in Thailand, 2006
por: Thavorncharoensap, Montarat, et al.
Publicado: (2010)

Economic costs of obesity in Thailand: a retrospective cost-of-illness study
por: Pitayatienanan, Paiboon, et al.
Publicado: (2014)

Pertussis seroprevalence in mother–infant pairs from India: role of maternal immunisation
por: Viswanathan, Rajlakshmi, et al.
Publicado: (2022)

The association between health costs and physical inactivity; analysis from the Physical Activity at Work study in Thailand
por: Akksilp, Katika, et al.
Publicado: (2023)

A systematic review of methodological approaches for evaluating real-world effectiveness of COVID-19 vaccines: Advising resource-constrained settings
por: Teerawattananon, Yot, et al.
Publicado: (2022)

Seasonal Influenza Vaccination for Children in Thailand: A Cost-Effectiveness Analysis
por: Meeyai, Aronrag, et al.
Publicado: (2015)

Retrospective secondary data analysis to identify high-cost users in inpatient department of hospitals in Thailand, a middle-income country with universal healthcare coverage
por: Rattanavipapong, Waranya, et al.
Publicado: (2021)

Is it worth offering a routine laparoscopic cholecystectomy in developing countries? A Thailand case study
por: Teerawattananon, Yot, et al.
Publicado: (2005)

Expanding access to high-cost medicines under the Universal Health Coverage scheme in Thailand: review of current practices and recommendations
por: Butani, Dimple, et al.
Publicado: (2023)

How Many People Experience Unsafe Medical Care in Thailand, and How Much Does It Cost under Universal Coverage Scheme?
por: Luankongsomchit, Vilawan, et al.
Publicado: (2023)

‘It takes two to tango’: Bridging the gap between country need and vaccine product innovation
por: Archer, Rachel A., et al.
Publicado: (2020)

The greatest happiness of the greatest number? Policy actors' perspectives on the limits of economic evaluation as a tool for informing health care coverage decisions in Thailand
por: Teerawattananon, Yot, et al.
Publicado: (2008)

Multi-criteria decision analysis for setting priorities on HIV/AIDS interventions in Thailand
por: Youngkong, Sitaporn, et al.
Publicado: (2012)

Government use licenses in Thailand: an assessment of the health and economic impacts
por: Yamabhai, Inthira, et al.
Publicado: (2011)

INADEQUATE PHYSICAL ACTIVITY ON HEALTHCARE EXPENDITURES AMONG MIDDLE AGE AND OLDER WORKING ADULTS IN THAILAND
por: Akksilp, Katika, et al.
Publicado: (2022)

A review of the costs of delivering maternal immunisation during pregnancy
por: Procter, Simon R, et al.
Publicado: (2020)

Pattern of OPD utilisation during the COVID-19 pandemic under the Universal Coverage Scheme in Thailand: what can 850 million records tell us?
por: Sukmanee, Jarawee, et al.
Publicado: (2023)

Scaling up cervical cancer screening in the midst of human papillomavirus vaccination advocacy in Thailand
por: Yothasamut, Jomkwan, et al.
Publicado: (2010)

Criteria for priority setting of HIV/AIDS interventions in Thailand: a discrete choice experiment
por: Youngkong, Sitaporn, et al.
Publicado: (2010)

A Data-Driven Analysis of the Economic Cost of Non-Pharmaceutical Interventions: A Cross-Country Comparison of Kenya, Singapore, and Thailand
por: Briones, Jamaica, et al.
Publicado: (2022)

The use of comparative effectiveness research to inform policy decisions on the inclusion of bevacizumab for the treatment of macular diseases in Thailand’s pharmaceutical benefit package
por: Anothaisintawee, Thunyarat, et al.
Publicado: (2012)

Pharmacist perceptions of new competency standards
por: Maitreemit, Pagamas, et al.
Publicado: (2008)

From Design to Evaluation: Applications of Health Technology Assessment in Myanmar and Lessons for Low or Lower Middle-Income Countries
por: Dabak, Saudamini Vishwanath, et al.
Publicado: (2019)

Advanced health biotechnologies in Thailand: redefining policy directions
por: Velasco, Román Pérez, et al.
Publicado: (2013)

FLT3 Gene Mutations in Acute Myeloid Leukemia Patients in Northeast Thailand
por: Aung, Nang Ei Ei, et al.
Publicado: (2022)

Assessing the cost-effectiveness of COVID-19 vaccines in a low incidence and low mortality setting: the case of Thailand at start of the pandemic
por: Wang, Yi, et al.
Publicado: (2022)

Effects of maternal and infant co-infections, and of maternal immunisation, on the infant response to BCG and tetanus immunisation
por: Elliott, Alison M., et al.
Publicado: (2010)

Do Pneumococcal Conjugate Vaccines Represent Good Value for Money in a Lower-Middle Income Country? A Cost-Utility Analysis in the Philippines
por: Haasis, Manuel Alexander, et al.
Publicado: (2015)

Evaluation of immunisation strategies for pertussis vaccines in Jinan, China – an interrupted time-series study
por: Liu, T. C., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_a78du0ndml6i07s268o82qhlfa